SCHEMBL31207830

SCHEMBL31207830

COC(=O)c1cc2cc(O)ccc2[nH]1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 11/20 0.67
PDGFRB P09619 4/20 0.67
KIT P10721 2/20 0.67
ABL1 P00519 1/20 0.67
BCR P11274 1/20 0.67
SMAD3 P84022 1/20 0.65
XDH P47989 2/20 0.61
PDGFRA P16234 2/20 0.58
CLK1 P49759 1/20 0.55
DYRK1A Q13627 1/20 0.55
HRH4 Q9H3N8 1/20 0.54
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HSD17B10 Q99714 1/20 0.51
NPC1 O15118 1/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL217022 1.00 FLT3 (0.67) FLT3PDGFRBKITABL1BCR
SCHEMBL2815266 0.87 FLT3 (0.56) FLT3PDGFRBKITABL1BCR
SCHEMBL30694751 0.83 XDH (0.61) PDGFRBXDHPDGFRAKDM4EALDH1A1
SCHEMBL31310313 0.83 RAB9A (0.72) FLT3PDGFRBXDHPDGFRAHRH4
SCHEMBL214096 0.83 RAB9A (0.72) FLT3PDGFRBXDHPDGFRAHRH4
SCHEMBL829213 0.83 KDM4E (0.76) FLT3PDGFRBKITABL1BCR
SCHEMBL617200 0.82 XDH (0.59) FLT3PDGFRBXDHPDGFRAHRH4
SCHEMBL3963537 0.82 F7 (0.66) FLT3PDGFRBXDHHRH4RAB9A
SCHEMBL217291 0.82 XDH (0.63) FLT3PDGFRBKITABL1BCR
SCHEMBL1104006 0.82 PDGFRB (0.77) FLT3PDGFRBXDHPDGFRAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118974040-A N- (3- (benzo [ B ] thiophen-2-amido) -phenyl) -2, 3-dihydrobenzo [ B ] [1,4] dioxin-6-amide derivatives and related compounds as lactic acid/ATP production inhibitors for the treatment of cancer 威马特股份公司 2024-11-15 CN disclosed